Optimizing Administration of Obinutuzumab: A Strategy to Minimize Infusion-Related Reactions.
- DOI
- 10.18176/jiaci.1193
- Published
- 2026 Jul 29
- Container
- Journal of investigational allergology & clinical immunology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.18176/jiaci.1193,
title = {Optimizing Administration of Obinutuzumab: A Strategy to Minimize Infusion-Related Reactions.},
author = {Gelis S and Villa L and Magnano L and Monge I and Muñoz-Cano R and Multidisciplinary Desensitization Team},
year = {2026},
journal = {Journal of investigational allergology \& clinical immunology},
doi = {10.18176/jiaci.1193},
url = {https://doi.org/10.18176/jiaci.1193}
}RIS
TY - JOUR TI - Optimizing Administration of Obinutuzumab: A Strategy to Minimize Infusion-Related Reactions. AU - Gelis S AU - Villa L AU - Magnano L AU - Monge I AU - Muñoz-Cano R AU - Multidisciplinary Desensitization Team PY - 2026 JO - Journal of investigational allergology & clinical immunology DO - 10.18176/jiaci.1193 UR - https://doi.org/10.18176/jiaci.1193 ER -
APA
S, G., L, V., L, M., I, M., R, M., & Team, M. D. (2026). Optimizing Administration of Obinutuzumab: A Strategy to Minimize Infusion-Related Reactions.. Journal of investigational allergology & clinical immunology. https://doi.org/10.18176/jiaci.1193
Source records
- pubmed · retrieved 2026-09-27T13:08:41.499Z